Cargando…

Changing the clinical course of glioma patients by preoperative motor mapping with navigated transcranial magnetic brain stimulation

BACKGROUND: Mapping of the motor cortex by navigated transcranial magnetic stimulation (nTMS) can be used for preoperative planning in brain tumor patients. Just recently, it has been proven to actually change outcomes by increasing the rate of gross total resection (GTR) and by reducing the surgery...

Descripción completa

Detalles Bibliográficos
Autores principales: Krieg, Sandro M, Sollmann, Nico, Obermueller, Thomas, Sabih, Jamil, Bulubas, Lucia, Negwer, Chiara, Moser, Tobias, Droese, Doris, Boeckh-Behrens, Tobias, Ringel, Florian, Meyer, Bernhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423137/
https://www.ncbi.nlm.nih.gov/pubmed/25884404
http://dx.doi.org/10.1186/s12885-015-1258-1
_version_ 1782370157294780416
author Krieg, Sandro M
Sollmann, Nico
Obermueller, Thomas
Sabih, Jamil
Bulubas, Lucia
Negwer, Chiara
Moser, Tobias
Droese, Doris
Boeckh-Behrens, Tobias
Ringel, Florian
Meyer, Bernhard
author_facet Krieg, Sandro M
Sollmann, Nico
Obermueller, Thomas
Sabih, Jamil
Bulubas, Lucia
Negwer, Chiara
Moser, Tobias
Droese, Doris
Boeckh-Behrens, Tobias
Ringel, Florian
Meyer, Bernhard
author_sort Krieg, Sandro M
collection PubMed
description BACKGROUND: Mapping of the motor cortex by navigated transcranial magnetic stimulation (nTMS) can be used for preoperative planning in brain tumor patients. Just recently, it has been proven to actually change outcomes by increasing the rate of gross total resection (GTR) and by reducing the surgery-related rate of paresis significantly in cohorts of patients suffering from different entities of intracranial lesions. Yet, we also need data that shows whether these changes also lead to a changed clinical course, and can also be achieved specifically in high-grade glioma (HGG) patients. METHODS: We prospectively enrolled 70 patients with supratentorial motor eloquently located HGG undergoing preoperative nTMS (2010–2014) and matched these patients with 70 HGG patients who did not undergo preoperative nTMS (2007–2010). RESULTS: On average, the overall size of the craniotomy was significantly smaller for nTMS patients when compared to the non-nTMS group (nTMS: 25.3 ± 9.7 cm(2); non-nTMS: 30.8 ± 13.2 cm(2); p = 0.0058). Furthermore, residual tumor tissue (nTMS: 34.3%; non-nTMS: 54.3%; p = 0.0172) and unexpected tumor residuals (nTMS: 15.7%; non-nTMS: 32.9%; p = 0.0180) were less frequent in nTMS patients. Regarding the further clinical course, median inpatient stay was 12 days for the nTMS and 14 days for the non-nTMS group (nTMS: CI 10.5 – 13.5 days; non-nTMS: CI 11.6 – 16.4 days; p = 0.0446). 60.0% of patients of the nTMS group and 54.3% of patients of the non-nTMS group were eligible for postoperative chemotherapy (OR 1.2630, CI 0.6458 – 2.4710, p = 0.4945), while 67.1% of nTMS patients and 48.6% of non-nTMS patients received radiotherapy (OR 2.1640, CI 1.0910 – 4.2910, p = 0.0261). Moreover, 3, 6, and 9 months survival was significantly better in the nTMS group (p = 0.0298, p = 0.0015, and p = 0.0167). CONCLUSIONS: With the limitations of this study in mind, our data show that HGG patients might benefit from preoperative nTMS mapping.
format Online
Article
Text
id pubmed-4423137
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44231372015-05-08 Changing the clinical course of glioma patients by preoperative motor mapping with navigated transcranial magnetic brain stimulation Krieg, Sandro M Sollmann, Nico Obermueller, Thomas Sabih, Jamil Bulubas, Lucia Negwer, Chiara Moser, Tobias Droese, Doris Boeckh-Behrens, Tobias Ringel, Florian Meyer, Bernhard BMC Cancer Research Article BACKGROUND: Mapping of the motor cortex by navigated transcranial magnetic stimulation (nTMS) can be used for preoperative planning in brain tumor patients. Just recently, it has been proven to actually change outcomes by increasing the rate of gross total resection (GTR) and by reducing the surgery-related rate of paresis significantly in cohorts of patients suffering from different entities of intracranial lesions. Yet, we also need data that shows whether these changes also lead to a changed clinical course, and can also be achieved specifically in high-grade glioma (HGG) patients. METHODS: We prospectively enrolled 70 patients with supratentorial motor eloquently located HGG undergoing preoperative nTMS (2010–2014) and matched these patients with 70 HGG patients who did not undergo preoperative nTMS (2007–2010). RESULTS: On average, the overall size of the craniotomy was significantly smaller for nTMS patients when compared to the non-nTMS group (nTMS: 25.3 ± 9.7 cm(2); non-nTMS: 30.8 ± 13.2 cm(2); p = 0.0058). Furthermore, residual tumor tissue (nTMS: 34.3%; non-nTMS: 54.3%; p = 0.0172) and unexpected tumor residuals (nTMS: 15.7%; non-nTMS: 32.9%; p = 0.0180) were less frequent in nTMS patients. Regarding the further clinical course, median inpatient stay was 12 days for the nTMS and 14 days for the non-nTMS group (nTMS: CI 10.5 – 13.5 days; non-nTMS: CI 11.6 – 16.4 days; p = 0.0446). 60.0% of patients of the nTMS group and 54.3% of patients of the non-nTMS group were eligible for postoperative chemotherapy (OR 1.2630, CI 0.6458 – 2.4710, p = 0.4945), while 67.1% of nTMS patients and 48.6% of non-nTMS patients received radiotherapy (OR 2.1640, CI 1.0910 – 4.2910, p = 0.0261). Moreover, 3, 6, and 9 months survival was significantly better in the nTMS group (p = 0.0298, p = 0.0015, and p = 0.0167). CONCLUSIONS: With the limitations of this study in mind, our data show that HGG patients might benefit from preoperative nTMS mapping. BioMed Central 2015-04-08 /pmc/articles/PMC4423137/ /pubmed/25884404 http://dx.doi.org/10.1186/s12885-015-1258-1 Text en © Krieg et al.; licensee BioMed Central. 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Krieg, Sandro M
Sollmann, Nico
Obermueller, Thomas
Sabih, Jamil
Bulubas, Lucia
Negwer, Chiara
Moser, Tobias
Droese, Doris
Boeckh-Behrens, Tobias
Ringel, Florian
Meyer, Bernhard
Changing the clinical course of glioma patients by preoperative motor mapping with navigated transcranial magnetic brain stimulation
title Changing the clinical course of glioma patients by preoperative motor mapping with navigated transcranial magnetic brain stimulation
title_full Changing the clinical course of glioma patients by preoperative motor mapping with navigated transcranial magnetic brain stimulation
title_fullStr Changing the clinical course of glioma patients by preoperative motor mapping with navigated transcranial magnetic brain stimulation
title_full_unstemmed Changing the clinical course of glioma patients by preoperative motor mapping with navigated transcranial magnetic brain stimulation
title_short Changing the clinical course of glioma patients by preoperative motor mapping with navigated transcranial magnetic brain stimulation
title_sort changing the clinical course of glioma patients by preoperative motor mapping with navigated transcranial magnetic brain stimulation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423137/
https://www.ncbi.nlm.nih.gov/pubmed/25884404
http://dx.doi.org/10.1186/s12885-015-1258-1
work_keys_str_mv AT kriegsandrom changingtheclinicalcourseofgliomapatientsbypreoperativemotormappingwithnavigatedtranscranialmagneticbrainstimulation
AT sollmannnico changingtheclinicalcourseofgliomapatientsbypreoperativemotormappingwithnavigatedtranscranialmagneticbrainstimulation
AT obermuellerthomas changingtheclinicalcourseofgliomapatientsbypreoperativemotormappingwithnavigatedtranscranialmagneticbrainstimulation
AT sabihjamil changingtheclinicalcourseofgliomapatientsbypreoperativemotormappingwithnavigatedtranscranialmagneticbrainstimulation
AT bulubaslucia changingtheclinicalcourseofgliomapatientsbypreoperativemotormappingwithnavigatedtranscranialmagneticbrainstimulation
AT negwerchiara changingtheclinicalcourseofgliomapatientsbypreoperativemotormappingwithnavigatedtranscranialmagneticbrainstimulation
AT mosertobias changingtheclinicalcourseofgliomapatientsbypreoperativemotormappingwithnavigatedtranscranialmagneticbrainstimulation
AT droesedoris changingtheclinicalcourseofgliomapatientsbypreoperativemotormappingwithnavigatedtranscranialmagneticbrainstimulation
AT boeckhbehrenstobias changingtheclinicalcourseofgliomapatientsbypreoperativemotormappingwithnavigatedtranscranialmagneticbrainstimulation
AT ringelflorian changingtheclinicalcourseofgliomapatientsbypreoperativemotormappingwithnavigatedtranscranialmagneticbrainstimulation
AT meyerbernhard changingtheclinicalcourseofgliomapatientsbypreoperativemotormappingwithnavigatedtranscranialmagneticbrainstimulation